Delivery Of RNA Therapeutics: VitalDose® EVA Drug Delivery Platform

Biologics are gaining market share but face challenges in formulation and delivery. Celanese's VitalDose® EVA drug delivery platform addresses these challenges by providing a proven platform for both systemic and localized delivery of biologic drugs.

The VitalDose® EVA platform utilizes ethylene vinyl acetate (EVA) copolymer to deliver medications through implants. It offers benefits such as compatibility with various drug types, patient-centric dosage, and a long history of commercialized use.

This brochure addresses hurdles like reduced dosing frequency, more stable drug levels, reduced toxicity, improved specificity, and improved patient experience. It's a valuable tool for pharmaceutical formulators seeking effective and efficient delivery of biologic drugs.